Pharmacogenomics in pediatric oncology: possibility to overcome drug-induced toxicity of anticancer treatment
Background. Short-term and long-term toxicities of anticancer treatment are of increasing relevance, especially in children. Adverse events of anticancer treatment can cause mortality, organ toxicity of varying severity, subsequent disability, significant negative impact on psychosocial functioning...
Saved in:
| Main Authors: | Yu. V. Dinikina, E. N. Imyanitov, M. B. Belogurova, I. L. Nikitina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2024-01-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/1165 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Pharmacogenomics for improving drug safety and efficacy in cancer
by: Zhiyao He, et al.
Published: (2025-07-01) -
Pharmacogenomics of TNF inhibitors
by: Zainab Jan, et al.
Published: (2025-05-01) -
Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by: Simran Maggo, et al.
Published: (2025-05-01) -
Correction: Clinical impact of pharmacogenomics in pediatric care: insights extracted from clinical exome sequencing
by: Simran Maggo, et al.
Published: (2025-07-01) -
Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study
by: Rachel Conyers, et al.
Published: (2025-04-01)